Abstract
Neoplasms of the pancreas exhibit a vast array of morphologic and clinical features, ranging from benign proliferations to the deadliest cancers. The normal pancreas is composed of distinct cellular compartments, and these compartments provide a broad framework for morphological classification of pancreatic neoplasms. This morphologic classification divides pancreatic neoplasms into distinct groups with diverse clinical and molecular features. On a molecular level, pancreatic neoplasms occur due to the accumulation of mutations in oncogenes and tumor suppressor genes that transform a normal pancreatic cell through various neoplastic precursors into invasive neoplasm. The specific genes affected by these molecular alterations vary based on the type of neoplasm—for example, the genes altered in infiltrating ductal adenocarcinomas are quite different from those altered in pancreatic neuroendocrine tumors or acinar cell carcinomas, illustrating that each pancreatic neoplasm possesses a distinct profile of genetic changes. These unique molecular alterations form a basis for specific diagnostic tests to discriminate pancreatic neoplasms, and molecular analyses of clinical samples show promise in further advancing the diagnosis and treatment of pancreatic neoplasms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Further Reading
Abraham SC, Klimstra DC, Wilentz RE, et al. Solid pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160:1361–9.
Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol. 2002;160:953–62.
Abraham SC, Wu TT, Klimstra DC, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol. 2001;159:1619–27.
Agaimy A, Haller F, Frohnauer J, et al. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol. 2014;28:248–60.
Elias KM, Tsantoulis P, Tille J-C, et al. Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors. J Pathol. 2018;246:459–69.
Felsenstein M, Noë M, Masica DL, et al. IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut. 2018;67:1652–62.
Fischer CG, Guthrie VB, Braxton AM, et al. Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations. Gastroenterology. 2019;157:1123–37.
Fujikura K, Hosoda W, Felsenstein M, et al. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions. Gut. 2021;70(5):928–39. https://doi.org/10.1136/gutjnl-2020-321217.
Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579–86.
Hruban RH, Canto MI, Goggins M, et al. Update on familial pancreatic cancer. Adv Surg. 2010;44:293–311.
Hruban RH, Pittman MC, Klimstra DS. AFIP atlas of tumor pathology: tumors of the pancreas. Washington, DC: American Registry of Pathology; 2007.
Hutchings D, Jiang Z, Skaro M, et al. Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants. Mod Pathol. 2019;32:1806–13.
Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331:1199–203.
Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801–6.
Kasajima A, Konukiewitz B, Schlitter AM, et al. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features. Virchows Arch. 2022;480:359–68.
Klimstra DS, Adsay V. Acinar neoplasms of the pancreas-a summary of 25 years of research. Semin Diagn Pathol. 2016;33:307–18.
Kuboki Y, Fischer CG, Guthrie VB, et al. Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. J Pathol. 2019;247:347–56.
Luchini C, Pea A, Lionheart G, et al. Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma. J Pathol. 2017;243:148–54.
Moffitt RA, Marayati R, Flate EL, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47:1168–78.
Noë M, Niknafs N, Fischer CG, et al. Genomic characterization of malignant progression in neoplastic pancreatic cysts. Nat Commun. 2020;11:4085.
The Cancer Genome Atlast Research Network. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017;32:185–203.
Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–99.
Vortmeyer AO, Lubensky IA, Fogt F, et al. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol. 1997;151:951–6.
Waddell N, Pajic M, Patch A-M, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495–501.
WHO Classification of Tumors Editorial Board. WHO classification of tumours: digestive system. Lyon: International Agency for Research on Cancer; 2019.
Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011;108:1188–93.
Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lee, J.W., Adsay, N.V., Hruban, R.H., Wood, L.D. (2023). Molecular Pathology of Pancreatic Tumors. In: Cheng, L., Netto, G.J., Eble, J.N. (eds) Molecular Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-35118-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-031-35118-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-35117-4
Online ISBN: 978-3-031-35118-1
eBook Packages: MedicineMedicine (R0)